The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Clinical targeting of the TNF and TNFR superfamilies
Open accessAbstract
Inhibitors of tumour necrosis factor (TNF) are among the most successful protein-based drugs (biologics) and have proven to be clinically efficacious at reducing inflammation associated with several autoimmune diseases. As a result, attention is focusing on the therapeutic potential of additional members of the TNF superfamily of structurally related cytokines. Many of these TNF-related cytokines or their cognate receptors are now in preclinical or clinical development as possible targets for modulating inflammatory diseases and cancer as well as other indications. This Review focuses on the biologics that are currently in clinical trials for immune-related diseases and other syndromes, discusses the successes and failures to date as well as the expanding therapeutic potential of modulating the activity of this superfamily of molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tai, Y., Catley, L. P., Mitsiades, C. S., Burger, R., Podar, K., Shringpaure, R., Hideshima, T., Chauhan, D., Hamasaki, M., Ishitsuka, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3630 · Cited by 130
RetractedThe TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Morgan, R. A., Yang, J. C., Kitano, M., Dudley, M. E., Laurencot, C. M., & Rosenberg, S. A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.24 · Cited by 2,533
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Navarra, S. V., Guzmán, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K.-M., Thomas, M., Kim, H.-Y., León, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,074
Furie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sanchez-Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,683
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Younes, A., Gopal, A. K., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Ramchandren, R., Bartlett, N. L., Cheson, B. D., de Vos, S., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0410 · Cited by 1,529
TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
The many roles of FAS receptor signaling in the immune system
Strasser, A., Jost, P. J., & Nagata, S. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.001 · Cited by 968
Francisco, J. A., Cerveny, C. G., Meyer, D. L., Mixan, B. J., Klussman, K., Chace, D. F., Rejniak, S. X., Gordon, K. A., DeBlanc, R., Toki, B. E., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0039 · Cited by 931
Mackay, F., & Schneider, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2572 · Cited by 930
The role of TNF superfamily members in T-cell function and diseases
Croft, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2526 · Cited by 920
Self-citationThe molecular architecture of the TNF superfamily
Bodmer, J.-L., Schneider, P., & Tschopp, J. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01995-8 · Cited by 916
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 913
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Sandborn, W. J., Hanauer, S. B., Katz, S., Safdi, M., Wolf, D. G., Baerg, R. D., Tremaine, W. J., Johnson, T., Diehl, N. N., & Zinsmeister, A. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28674 · Cited by 910
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1148 · Cited by 863
Self-citationImai, C., Mihara, K., Andreansky, M., Nicholson, I. C., Pui, C.-H., Geiger, T. L., & Campana, D. (2004) · Leukemia · doi:10.1038/sj.leu.2403302 · Cited by 840
van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J. B., Bertelsmann, F. W., von Blomberg, B. M. E., Woody, J. N., Hartung, H.-P., & Polman, C. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1531 · Cited by 733
TACI is mutant in common variable immunodeficiency and IgA deficiency
Castigli, E., Wilson, S. A., Garibyan, L., Rachid, R., Bonilla, F., Schneider, L., & Geha, R. S. (2005) · Nature Genetics · doi:10.1038/ng1601 · Cited by 702
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
Lacey, D. L., Boyle, W. J., Simonet, W. S., Kostenuik, P. J., Dougall, W. C., Sullivan, J. K., Martin, J. S., & Dansey, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3705 · Cited by 694
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
Kawai, T., Andrews, D., Colvin, R. B., Sachs, D. H., & Cosimi, A. B. (2000) · Nature Medicine · doi:10.1038/72162 · Cited by 692
Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
Lane, N. E., Schnitzer, T. J., Birbara, C. A., Mokhtarani, M., Shelton, D. L., Smith, M. D., & Brown, M. T. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0901510 · Cited by 674
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639
Boumpas, D. T., Furie, R., Manzi, S., Illei, G. G., Wallace, D. J., Balow, J. E., Vaishnaw, A., & on behalf of the BG9588 Lupus Nephritis Trial Group (2003) · Arthritis & Rheumatism · doi:10.1002/art.10856 · Cited by 618
The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
Winkles, J. A. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2488 · Cited by 601
Lichtenstein, G. R., Yan, S., Bala, M., Blank, M., & Sands, B. E. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.048 · Cited by 597
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Croft, M. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101243 · Cited by 548
Self-citationDi Stasi, A., De Angelis, B., Rooney, C. M., Zhang, L., Mahendravada, A., Foster, A. E., Heslop, H. E., Brenner, M. K., Dotti, G., & Savoldo, B. (2009) · Blood · doi:10.1182/blood-2009-03-209650 · Cited by 533
Vonderheide, R. H., Flaherty, K. T., Khalil, M., Stumacher, M. S., Bajor, D. L., Hutnick, N. A., Sullivan, P., Mahany, J. J., Gallagher, M., Kramer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.3311 · Cited by 513
The effect of a single dose of osteoprotegerin in postmenopausal women.
Bekker, P. J., Holloway, D., Nakanishi, A., Arrighi, M., Leese, P. T., & Dunstan, C. R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.348 · Cited by 484
Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
Benson, M. J., Dillon, S. R., Castigli, E., Geha, R. S., Xu, S., Lam, K.-P., & Noelle, R. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3655 · Cited by 478
Osteoprotegerin Deficiency and Juvenile Paget's Disease
Whyte, M. P., Obrecht, S. E., Finnegan, P. M., Jones, J. L., Podgornik, M. N., McAlister, W. H., & Mumm, S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013096 · Cited by 445
NETWORK COMMUNICATIONS: Lymphotoxins, LIGHT, and TNF
Ware, C. F. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115719 · Cited by 441
Self-citationAshkenazi, A., Holland, P., & Eckhardt, S. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7198 · Cited by 421
Seshasayee, D., Valdez, P., Yan, M., Dixit, V. M., Tumas, D., & Grewal, I. S. (2003) · Immunity · doi:10.1016/s1074-7613(03)00025-6 · Cited by 400
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Gregory, A. P., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., Poschmann, G., Kaur, G., Lambert, L., Leach, O. A., et al. (2012) · Nature · doi:10.1038/nature11307 · Cited by 384
Body, J.-J., Greipp, P., Coleman, R. E., Facon, T., Geurs, F., Fermand, J.-P., Harousseau, J.-L., Lipton, A., Mariette, X., Williams, C. D., et al. (2003) · Cancer · doi:10.1002/cncr.11138 · Cited by 383
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Haybaeck, J., Zeller, N., Wolf, M. J., Weber, A., Wagner, U., Kurrer, M. O., Bremer, J., Iezzi, G., Graf, R., Clavien, P.-A., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.021 · Cited by 383
Papapoulos, S., Chapurlat, R., Libanati, C., Brandi, M. L., Brown, J. P., Czerwiński, E., Krieg, M.-A., Man, Z., Mellström, D., Radominski, S. C., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1479 · Cited by 344
Kalunian, K. C., Davis, J. C., Merrill, J. T., Totoritis, M. C., Wofsy, D., & for the IDEC‐131 Lupus Study Group (2002) · Arthritis & Rheumatism · doi:10.1002/art.10681 · Cited by 336
4-1BB-mediated immunotherapy of rheumatoid arthritis
Seo, S. K., Choi, J. H., Kim, Y. H., Kang, W. J., Park, H. Y., Suh, J. H., Choi, B. K., Vinay, D. S., & Kwon, B. S. (2004) · Nature Medicine · doi:10.1038/nm1107 · Cited by 325
Nolte, M. A., Van Olffen, R. W., Van Gisbergen, K. P. J. M., & Van Lier, R. A. W. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00774.x · Cited by 305
Tamada, K., Shimozaki, K., Chapoval, A. I., Zhu, G., Sica, G., Flies, D., Boone, T., Hsu, H., Fu, Y.-X., Nagata, S., et al. (2000) · Nature Medicine · doi:10.1038/73136 · Cited by 303
Weinblatt, M., Schiff, M., Goldman, A., Kremer, J., Luggen, M., Li, T., Chen, D., & Becker, J.-C. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055111 · Cited by 300
Dall'Era, M., Chakravarty, E., Wallace, D., Genovese, M., Weisman, M., Kavanaugh, A., Kalunian, K., Dhar, P., Vincent, E., Pena‐Rossi, C., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23047 · Cited by 294
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
Furst, D. E. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.10.002 · Cited by 291
CD40 and autoimmunity: The dark side of a great activator
Peters, A. L., Stunz, L. L., & Bishop, G. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.012 · Cited by 270
OX40 (CD134) Controls Memory T Helper 2 Cells that Drive Lung Inflammation
Salek-Ardakani, S., Song, J., Halteman, B. S., Jember, A. G.-H., Akiba, H., Yagita, H., & Croft, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021937 · Cited by 256
Self-citationRennert, P., Schneider, P., Cachero, T. G., Thompson, J., Trabach, L., Hertig, S., Holler, N., Qian, F., Mullen, C., Strauch, K., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1677 · Cited by 252
Forero‐Torres, A., Leonard, J. P., Younes, A., Rosenblatt, J. D., Brice, P., Bartlett, N. L., Bosly, A., Pinter‐Brown, L., Kennedy, D., Sievers, E. L., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07740.x · Cited by 249
Wilson, N. S., Yang, B., Yang, A., Loeser, S., Marsters, S., Lawrence, D., Li, Y., Pitti, R., Totpal, K., Yee, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.012 · Cited by 248
Soria, J.-C., Márk, Z., Zatloukal, P., Szima, B., Albert, I., Juhász, E., Pujol, J.-L., Kozielski, J., Baker, N., Smethurst, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2623 · Cited by 246
The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
Steinberg, M. W., Cheung, T. C., & Ware, C. F. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01064.x · Cited by 243
Self-citationEfficacy and safety of tanezumab in the treatment of chronic low back pain
Katz, N., Borenstein, D. G., Birbara, C., Bramson, C., Nemeth, M. A., Smith, M. D., & Brown, M. T. (2011) · Pain · doi:10.1016/j.pain.2011.05.003 · Cited by 243
Yang, M., Sun, L., Wang, S., Ko, K.-H., Xu, H., Zheng, B.-J., Cao, X., & Lu, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902551 · Cited by 242
Savoldo, B., Rooney, C. M., Di Stasi, A., Abken, H., Hombach, A., Foster, A. E., Zhang, L., Heslop, H. E., Brenner, M. K., & Dotti, G. (2007) · Blood · doi:10.1182/blood-2006-11-059139 · Cited by 234
TNF superfamily in inflammatory disease: translating basic insights
Croft, M., Duan, W., Choi, H., Eun, S.-Y., Madireddi, S., & Mehta, A. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.10.004 · Cited by 231
Self-citationShaikh, R. B., Santee, S., Granger, S. W., Butrovich, K., Cheung, T., Kronenberg, M., Cheroutre, H., & Ware, C. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6330 · Cited by 230
Self-citationChiu, A., Xu, W., He, B., Dillon, S. R., Gross, J. A., Sievers, E., Qiao, X., Santini, P., Hyjek, E., Lee, J.-W., et al. (2007) · Blood · doi:10.1182/blood-2006-04-015958 · Cited by 228
Olofsson, P. S., Söderström, L. A., Wågsäter, D., Sheikine, Y., Ocaya, P., Lang, F., Rabu, C., Chen, L., Rudling, M., Aukrust, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.699173 · Cited by 223
Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin
Falini, B., Flenghi, L., Aversa, F., Barbabietola, G., Martelli, M. F., Comeli, P., Tazzari, P. L., Broe, M. K., Stein, H., Dürkop, H., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)91135-u · Cited by 216
Fanale, M. A., Forero-Torres, A., Rosenblatt, J. D., Advani, R. H., Franklin, A. R., Kennedy, D. A., Han, T. H., Sievers, E. L., & Bartlett, N. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1425 · Cited by 213
Wahl, A. F., Klussman, K., Thompson, J. D., Chen, J. H., Francisco, L. V., Risdon, G., Chace, D. F., Siegall, C. B., & Francisco, J. A. (2002) · PubMed · Cited by 211
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
Burkly, L. C., Michaelson, J. S., & Zheng, T. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01054.x · Cited by 208
In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation
Seshasayee, D., Lee, W. P., Zhou, M., Shu, J., Suto, E., Zhang, J., Diehl, L., Austin, C. D., Meng, Y. G., Tan, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33559 · Cited by 207
Sznol, M., Hodi, F. S., Margolin, K., McDermott, D. F., Ernstoff, M. S., Kirkwood, J. M., Wojtaszek, C., Feltquate, D., & Logan, T. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3007 · Cited by 204
Dougall, W. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2507 · Cited by 198
Tumor necrosis factor blockade and the risk of viral infection
Kim, S. Y., & Solomon, D. H. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.279 · Cited by 197
Brown, M. T., Murphy, F. T., Radin, D. M., Davignon, I., Smith, M. D., & West, C. R. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.05.006 · Cited by 195
Kindler, H. L., Richards, D. A., Garbo, L. E., Garon, E. B., Stephenson, J. J., Rocha-Lima, C. M., Safran, H., Chan, D., Kocs, D. M., Galimi, F., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds142 · Cited by 193
CD95, BIM and T cell homeostasis
Bouillet, P., & O'Reilly, L. A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2570 · Cited by 190
Adams, A. B., Shirasugi, N., Jones, T. R., Durham, M. M., Strobert, E. A., Cowan, S., Rees, P., Hendrix, R., Price, K., Kenyon, N. S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.542 · Cited by 183
APRIL-Deficient Mice Have Normal Immune System Development
Varfolomeev, E., Kischkel, F., Martin, F., Seshasayee, D., Wang, H., Lawrence, D., Olsson, C., Tom, L., Erickson, S., French, D., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.997-1006.2004 · Cited by 183
Schmaltz, C., Alpdogan, O., Horndasch, K. J., Muriglan, S. J., Kappel, B. J., Teshima, T., Ferrara, J. L. M., Burakoff, S. J., & van den Brink, M. R. M. (2001) · Blood · doi:10.1182/blood.v97.9.2886 · Cited by 181
Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease
Chiang, E. Y., Kolumam, G. A., Yu, X., Francesco, M., Ivelja, S., Peng, I., Gribling, P., Shu, J., Lee, W. P., Refino, C. J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1984 · Cited by 181
Whyte, M. P., & Hughes, A. E. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.26 · Cited by 180
Trarbach, T., Moehler, M., Heinemann, V, Köhne, C.-H., Przyborek, M., Schulz, C., Sneller, V, Gallant, G., & Kanzler, S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605507 · Cited by 180
Niu, L., Strahotin, S., Hewes, B., Zhang, B., Zhang, Y., Archer, D., Spencer, T., Dillehay, D., Kwon, B., Chen, L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4194 · Cited by 171
The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling
Doherty, T. A., Soroosh, P., Khorram, N., Fukuyama, S., Rosenthal, P., Cho, J. Y., Norris, P. S., Choi, H., Scheu, S., Pfeffer, K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2356 · Cited by 171
Self-citationCamidge, D. R., Herbst, R. S., Gordon, M. S., Eckhardt, S. G., Kurzrock, R., Durbin, B., Ing, J., Tohnya, T. M., Sager, J., Ashkenazi, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1267 · Cited by 169
van Vollenhoven, R. F., Kinnman, N., Vincent, E., Wax, S., & Bathon, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30372 · Cited by 167
The discovery and development of belimumab: the anti-BLyS–lupus connection
Stohl, W., & Hilbert, D. M. (2012) · Nature Biotechnology · doi:10.1038/nbt.2076 · Cited by 166
Fisher, T. S., Kamperschroer, C., Oliphant, T., Love, V. A., Lira, P. D., Doyonnas, R., Bergqvist, S., Baxi, S. M., Rohner, A., Shen, A. C., et al. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1237-1 · Cited by 166
Tai, Y.-T., Li, X., Tong, X., Santos, D., Otsuki, T., Catley, L., Tournilhac, O., Podar, K., Hideshima, T., Schlossman, R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4125 · Cited by 158
Rüter, J., Antonia, S. J., Burris, H. A., Huhn, R. D., & Vonderheide, R. H. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.10.13251 · Cited by 155
Law, C., Gordon, K. A., Toki, B. E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2883 · Cited by 152
CD40-Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates
Thompson, P., Cardona, K., Russell, M. C., Badell, I. R., Shaffer, V. O., Korbutt, G. S., Rayat, G. R., Cano, J., Song, M., Jiang, W., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03509.x · Cited by 151
Davis, J. C., Totoritis, M. C., Rosenberg, J., Sklenar, T. A., & Wofsy, D. (2001) · PubMed · Cited by 146
Hussein, M. A., Berenson, J. R., Niesvizky, R., Munshi, N. C., Matouš, J., Sobecks, R. M., Harrop, K. L., Drachman, J. G., & Whiting, N. C. (2010) · Haematologica · doi:10.3324/haematol.2009.008003 · Cited by 142
Buchsbaum, D. J., Zhou, T., Grizzle, W. E., Oliver, P. G., Hammond, C., Zhang, S., Carpenter, M., & LoBuglio, A. F. (2003) · PubMed · Cited by 141
Pastor, F., Kolonias, D. S., McNamara, J. O., & Gilboa, E. (2011) · Molecular Therapy · doi:10.1038/mt.2011.145 · Cited by 139
TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
Hellwig, C. T., & Rehm, M. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0434 · Cited by 136
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma
Younes, A., Vose, J. M., Zelenetz, A. D., Smith, M. R., Burris, H. A., Ansell, S. M., Klein, J., Halpern, W., Miceli, R. C., Kumm, E., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605987 · Cited by 132
Meylan, F., Richard, A. C., & Siegel, R. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01068.x · Cited by 132
Atacicept: targeting B cells in multiple sclerosis
Hartung, H., & Kieseier, B. C. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610371146 · Cited by 129
Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates
Haanstra, K. G., Ringers, J., Sick, E. A., Ramdien‐Murli, S., Kuhn, E.-M., Boon, L., & Jonker, M. (2003) · Transplantation · doi:10.1097/01.tp.0000054835.58014.c2 · Cited by 125
Targeting the Lymphotoxin-β Receptor with Agonist Antibodies as a Potential Cancer Therapy
Lukashev, M., LePage, D., Wilson, C. A., Bailly, V., Garber, E. A., Lukashin, A., Ngam-ek, A., Zeng, W., Allaire, N., Perrin, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0217 · Cited by 125
Deodhar, A. A., Dore, R. K., Mandel, D. R., Schechtman, J., Shergy, W. J., Trapp, R. G., Ory, P. A., PETERFY, C. G., Fuerst, T. P., Wang, H., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20004 · Cited by 124
Genovese, M. C., Kinnman, N., Bourdonnaye, G. D. L., Rossi, C. P., & Tak, P. P. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30373 · Cited by 123
T‐cell intrinsic effects of GITR and 4‐1BB during viral infection and cancer immunotherapy
Snell, L. M., Lin, G. H. Y., McPherson, A. J., Moraes, T. J., & Watts, T. H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01063.x · Cited by 122
Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain
Schnitzer, T. J., Lane, N. E., Birbara, C. A., Smith, M. D., Simpson, S. L., & Brown, M. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.01.009 · Cited by 120
Vetto, J. T., Lum, S. S., Morris, A. M., Sicotte, M., Davis, J. L., Lemon, M., & Weinberg, A. D. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00139-6 · Cited by 120
Bamias, G., Siakavellas, S. I., Stamatelopoulos, K., Chryssochoou, E., Papamichael, C. M., & Sfikakis, P. P. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.014 · Cited by 119
Nakatsuka, K., Nishizawà, Y., & Ralston, S. H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.8.1381 · Cited by 119
Furman, R. R., Forero, A., Shustov, A. R., & Drachman, J. G. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903440946 · Cited by 118
Role of TWEAK in lupus nephritis: A bench-to-bedside review
Michaelson, J. S., Wisniacki, N., Burkly, L. C., & Putterman, C. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.003 · Cited by 117
McClung, M. R., Lewiecki, E. M., Geller, M. L., Bolognese, M. A., Peacock, M., Weinstein, R. L., Ding, B., Rockabrand, E., Wagman, R. B., & Miller, P. D. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2052-4 · Cited by 116
Dubrot, J., Milheiro, F., Alfaro, C., Palazón, A., Martínez‐Forero, I., Perez‐Gracia, J. L., Morales‐Kastresana, A., Romero-Trevejo, J. L., Ochoa, M. C., Hervás‐Stubbs, S., et al. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0846-9 · Cited by 115
Byrd, J. C., Kipps, T. J., Flinn, I. W., Cooper, M., Odenike, O. M., Bendiske, J., Rediske, J. J., Bilic, S., Dey, J., Baeck, J., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.681655 · Cited by 112
The BLyS Family: Toward a Molecular Understanding of B Cell Homeostasis
Treml, J., Hao, Y., Stadanlick, J. E., & Cancro, M. P. (2008) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-008-9036-1 · Cited by 109
Ware, C. F., & Šedý, J. R. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.008 · Cited by 107
Self-citationMcEarchern, J. A., Oflazoglu, E., Francisco, L. V., McDonagh, C. F., Gordon, K. A., Stone, I. J., Klussman, K., Turcott, E., van Rooijen, N., Carter, P. M., et al. (2006) · Blood · doi:10.1182/blood-2006-07-034017 · Cited by 106
Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease
Browning, J. L. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00633.x · Cited by 105
Petty, J. K., He, K., Corless, C. L., Vetto, J. T., & Weinberg, A. D. (2002) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)00831-0 · Cited by 104
Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges
Law, C., & Grewal, I. S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_2 · Cited by 102
Role of glucocorticoid‐induced TNF receptor family gene (GITR) in collagen‐induced arthritis
Cuzzocrea, S., Ayroldi, E., Paola, R. D., Agostini, M., Mazzon, E., Bruscoli, S., Genovese, T., Ronchetti, S., Caputi, A. P., & Riccardi, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-3556com · Cited by 94
Schüler, W., Bigaud, M., Brinkmann, V., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000116563.72763.83 · Cited by 90
Ryan, M. C., Kostner, H., Gordon, K. A., Duniho, S. M., Sutherland, M. K., Yu, C., Kim, K. M., Nesterova, A., Anderson, M. E., McEarchern, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605816 · Cited by 88
Huntington, N. D., Tomioka, R., Clavarino, C., Chow, A. M., Liñares, D., Maña, P., Rossjohn, J., Cachero, T. G., Qian, F., Kalled, S. L., et al. (2006) · International Immunology · doi:10.1093/intimm/dxl080 · Cited by 88
Jung, H. W., Choi, S. W., Choi, J. I., & Kwon, B. S. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.2 · Cited by 86
Bamias, G., Evangelou, K., Vergou, T., Tsimaratou, K., Kaltsa, G., Antoniou, C., Kotsinas, A., Kim, S., Gorgoulis, V. G., Stratigos, A., et al. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01304.x · Cited by 85
Kasran, A., Boon, L., Wortel, C. H., van Hogezand, R. A., Schreiber, S., Goldin, E., BOER, M. D., Geboes, K., Rutgeerts, P. J., & Ceuppens, J. L. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02526.x · Cited by 85
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives
Nocentini, G., Ronchetti, S., Petrillo, M. G., & Riccardi, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01753.x · Cited by 83
Kawashima, R., Kawamura, Y. I., Oshio, T., Son, A., Yamazaki, M., Hagiwara, T., Okada, T., Inagaki-Ohara, K., Wu, P., Szak, S. T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.040 · Cited by 83
Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms
Culp, P., Choi, D., Zhang, Y., Yin, J., Seto, P., Ybarra, S. E., Su, M., Sho, M., Steinle, R., Wong, M. H. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1929 · Cited by 82
BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
Zhou, X., Xia, Z., Lan, Q., Wang, J., Su, W., Han, Y.-P., Fan, H., Liu, Z., Stohl, W., & Zheng, S. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023629 · Cited by 77
Enhancement of Anti-Tumor Immunity Through Local Modulation of CTLA-4 and GITR by Dendritic Cells
Pruitt, S. K., Boczkowski, D., de Rosa, N., Haley, N. R., Morse, M. A., Tyler, D. S., Dannull, J., & Nair, S. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201141383 · Cited by 76
Rossi, J. M., Moreaux, J., Hose, D., Requirand, G., Rose, M., Rouille, V., Nestorov, I. A., Mordenti, G., Goldschmidt, H., Ythier, A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605241 · Cited by 76
Targeting CD30/CD30L in Oncology and Autoimmune and Inflammatory Diseases
Oflazoglu, E., Grewal, I. S., & Gerber, H. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_12 · Cited by 74
Cohavy, O., Zhou, J. S., Ware, C. F., & Targan, S. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.646 · Cited by 72
Self-citationWang, J., Zhao, W., Cheng, L., Guo, M., Li, D., Li, X., Tan, Y. J., Ma, S., Li, S., Yang, Y., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000927 · Cited by 70
Placke, T., Kopp, H., & Salih, H. R. (2010) · Journal of Immunology Research · doi:10.1155/2010/239083 · Cited by 70
Long-Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates
Oura, T., Yamashita, K., Suzuki, T., Fukumori, D., Watanabe, M., Hirokata, G., Wakayama, K., Taniguchi, M., Shimamura, T., Miura, T., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04014.x · Cited by 69
Demetri, G. D., Cesne, A. L., Chawla, S. P., Brodowicz, T., Maki, R. G., Bach, B. A., Smethurst, D. P., Bray, S. L., Hei, Y.-J., & Blay, J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.008 · Cited by 68
TRAIL death receptors and cancer therapeutics
Huang, Y., & Sheikh, M. S. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.007 · Cited by 67
Nuffel, A. M. T. V., Benteyn, D., Wilgenhof, S., Corthals, J., Heirman, C., Neyns, B., Thielemans, K., & Bonehill, A. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1176-2 · Cited by 66
Targeting tumors with LIGHT to generate metastasis-clearing immunity
Yu, P., & Fu, Y. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.004 · Cited by 66
Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis
Sharp, J. T., Tsuji, W. H., Ory, P. A., Harper-Barek, C., Wang, H., & Newmark, R. (2010) · Arthritis Care & Research · doi:10.1002/acr.20172 · Cited by 65
Dohi, T., & Burkly, L. C. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112042 · Cited by 64
Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease
Miwa, K., Hashimoto, H., Yatomi, T., Nakamura, N., Nagata, S., & Suda, T. (1999) · International Immunology · doi:10.1093/intimm/11.6.925 · Cited by 64
Bae, E. M., Kim, W.-J., Suk, K., Kang, Y. M., Park, J.-E., Kim, W. Y., Choi, E. M., Choi, B. K., Kwon, B. S., & Lee, W. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.05.013 · Cited by 63
Fox, N. L., Humphreys, R. C., Luster, T. A., Klein, J. L., & Gallant, G. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903319656 · Cited by 62
Johnson-Pais, T., Singer, F. R., Bone, H., McMurray, C., Hansen, M., & Leach, R. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.376 · Cited by 59
Blum, K. A., Jung, S., Johnson, J. L., Lin, T. S., Hsi, E. D., Lucas, D. M., Byrd, J. C., Cheson, B. D., & Bartlett, N. L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq211 · Cited by 59
Kelley, S. K., Gelzleichter, T. R., Xie, D., Lee, W. P., Darbonne, W. C., Qureshi, F., Kissler, K. M., Oflazoglu, E., & Grewal, I. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706828 · Cited by 59
Withers, D. R., Gaspal, F., Bekiaris, V., McConnell, F. M., Kim, M., Anderson, G., & Lane, P. J. L. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01057.x · Cited by 58
Schabowsky, R.-H., Elpek, K. G., Madireddi, S., Sharma, R. K., Yolcu, E. S., Bandura‐Morgan, L., Miller, R. E., MacLeod, K. J., Mittler, R. S., & Shirwan, H. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.127 · Cited by 58
Kelley, S. K., Gelzleichter, T. R., Xie, D., Lee, W. P., Darbonne, W. C., Qureshi, F., Kissler, K. M., Oflazoglu, E., & Grewal, I. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707129 · Cited by 58
Guadagnoli, M., Kimberley, F. C., Phan, U., Cameron, K., Vink, P. M., Rodermond, H. M., Eldering, E., Kater, A. P., van Eenennaam, H., & Medema, J. P. (2011) · Blood · doi:10.1182/blood-2011-01-330852 · Cited by 58
Lin, W. Y., Gong, Q., Seshasayee, D., Lin, Z., Ou, Q., Ye, S., Suto, E., Shu, J., Lee, W. P., Lee, C. V., et al. (2007) · Blood · doi:10.1182/blood-2007-04-088088 · Cited by 58
Weinberg, A. D., Thalhofer, C., Morris, N. P., Walker, J. M., Seiss, D., Wong, S. W., Axthelm, M. K., Picker, L. J., & Urba, W. J. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211319.00031.fc · Cited by 57
APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo
Eisele, G., Roth, P., Hasenbach, K., Aulwurm, S., Wolpert, F., Tabatabai, G., Wick, W., & Weller, M. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq176 · Cited by 57
Terenzi, A., Bolognesi, A., Pasqualucci, L., Flenghi, L., Pileri, S. A., Stein, H., Kadin, M. E., Bigerna, B., Polito, L., Tazzari, P. L., et al. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1995.404942.x · Cited by 53
APRIL (TNFSF13) regulates collagen‐induced arthritis, IL‐17 production and Th2 response
Xiao, Y., Motomura, S., & Podack, E. R. (2008) · European Journal of Immunology · doi:10.1002/eji.200838640 · Cited by 52
Development of an Fn14 agonistic antibody as an anti-tumor agent
Michaelson, J. S., Amatucci, A., Kelly, R., Su, L., Garber, E. A., Day, E. S., Berquist, L., Cho, S., Li, Y., Parr, M. J., et al. (2011) · mAbs · doi:10.4161/mabs.3.4.16090 · Cited by 51
Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis
Nestorov, I. A., Munafo, A., Papasouliotis, O., & Visich, J. E. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008315312 · Cited by 50
The role of core TNF/LIGHT family members in lymph node homeostasis and remodeling
Zhu, M., & Fu, Y. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01061.x · Cited by 50
Novel Functions of RANK(L) Signaling in the Immune System
Leibbrandt, A., & Penninger, J. M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1050-9_9 · Cited by 48
Wang, S., Shi, Y., Yang, M., Ma, J., Tian, J., Chen, J., Mao, C., Jiao, Z., Ko, K., Essien‐Baidoo, S., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.018 · Cited by 45
Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma
Wang, X., Zuo, D., Sarkar, D., & Fisher, P. B. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.629187 · Cited by 44
The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
Bhatnagar, S., & Kumar, A. (2011) · Current Molecular Medicine · doi:10.2174/156652412798376107 · Cited by 43
Bae, E. Y., Kim, W.-J., Kang, Y.-M., Suk, K., Koh, E., Cha, H.-S., Ahn, K., Huh, T.-L., & Lee, W.-H. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03363.x · Cited by 42
Tumor Necrosis Factor Receptor/Tumor Necrosis Factor Family Members in Antiviral CD8 T-Cell Immunity
Salek‐Ardakani, S., & Croft, M. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0026 · Cited by 41
Self-citationSchüngel, S., Buitrago‐Molina, L. E., Nalapareddy, P. D., Lebofsky, M., Manns, M. P., Jaeschke, H., Gross, A., & Vogel, A. (2009) · Hepatology · doi:10.1002/hep.23176 · Cited by 41
Emu, B., Luca, D., Offutt, C., Grogan, J. L., Rojkovich, B., Williams, M. B., Tang, M. T., Xiao, J. J., Lee, J. H., & Davis, J. C. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3554 · Cited by 41
Anti-NGF painkillers back on track?
Holmes, D. I. R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3732 · Cited by 40
Origins and functional basis of regulatory CD11c+CD8+ T cells
Vinay, D. S., Kim, C. H., Choi, B. K., & Kwon, B. S. (2009) · European Journal of Immunology · doi:10.1002/eji.200839057 · Cited by 39
Chao, D. T., Su, M., Tanlimco, S. G., Sho, M., Choi, D., Fox, M. D., Ye, S., Hsi, E. D., Durkin, L. M., Yin, J., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1332-x · Cited by 37
Anti-GITR antibodies--potential clinical applications for tumor immunotherapy.
Schaer, D., Cohen, A. D., & Wolchok, J. D. (2010) · PubMed · Cited by 35
Hart, B. A. ‘., Blezer, E. L. A., Brok, H., Boon, L., de Boer, M., Bauer, J., & Laman, J. D. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.005 · Cited by 33
Combining Radiotherapy with APO010 in Cancer Treatment
Verbrugge, I., Wissink, E. H. J., Rooswinkel, R. W., Jongsma, J., Beltraminelli, N., Dupuis, M., Borst, J. G., & Verheij, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2125 · Cited by 32
TNF superfamily: Costimulation and clinical applications
Vinay, D. S., & Kwon, B. S. (2009) · Cell Biology International · doi:10.1016/j.cellbi.2009.02.001 · Cited by 30
The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases
Shepard, B. D., & Badley, A. D. (2009) · Anti-Infective Agents · doi:10.2174/187152109787846060 · Cited by 29
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice
Kim, S. S., Richman, D. P., Zamvil, S. S., & Agius, M. A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.008 · Cited by 28
Sharma, S., de Vries, E. G. E., Infante, J. R., Oldenhuis, C. N. A. M., Chiang, L., Bilic, S., Goldbrunner, M., Scott, J. W., & Burris, H. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3538 · Cited by 25
Tecchio, C., Nadali, G., Scapini, P., Bonetto, C., Visco, C., Tamassia, N., Vassilakopoulos, T. P., Pangalis, G. A., Calzetti, F., Nardelli, B., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06615.x · Cited by 23
Liu, G.-Z., Gomes, A. C., Putheti, P., Karrenbauer, V. D., Kostulas, K., Press, R., Hillert, J. A., Hjelmström, P., & Gao, X. ‐. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01796.x · Cited by 23
Polymorphic Variants of LIGHT (TNF Superfamily-14) Alter Receptor Avidity and Bioavailability
Cheung, T. C., Coppieters, K. T., Sanjo, H., Oborne, L. M., Norris, P. S., Coddington, A., Granger, S. W., Elewaut, D. S., & Ware, C. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001159 · Cited by 21
Self-citationChiang, E. Y., Kolumam, G. A., McCutcheon, K. M., Young, J., Lin, Z., Balázs, M., & Grogan, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033106 · Cited by 21
Rossi, J. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.3816/clml.2011.n.031 · Cited by 15
Blocking the effects of NGF as a route to safe and effective pain relief – fact or fancy?
Hill, R. (2011) · Pain · doi:10.1016/j.pain.2011.06.015 · Cited by 13
TNF Conference 2009: Beyond Bones – RANKL/RANK in the Immune System
Leibbrandt, A., & Penninger, J. M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6612-4_2 · Cited by 10
TNFSF9 expression in primary biliary cirrhosis and its clinical significance
Xia, R., Tang, Y., Huang, Y., Yao, D., Zhou, Y., Chen, B., Chen, Y., Chen, S., Deng, A., & Zhong, R. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.001 · Cited by 7
Cited by
Immunotherapy in colorectal cancer: Rationale, challenges and potential
Ganesh, K., Stadler, Z. K., Cercek, A., Mendelsohn, R. B., Shia, J., Segal, N. H., & Diaz, L. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0126-x · Cited by 1,954
Osteoblast-Osteoclast Communication and Bone Homeostasis
Kim, J.-M., Lin, C., Stavre, Z., Greenblatt, M. B., & Shim, J.-H. (2020) · Cells · doi:10.3390/cells9092073 · Cited by 1,178
Regulation of tumour necrosis factor signalling: live or let die
Brenner, D., Blaser, H., & Mak, T. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3834 · Cited by 998
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
Death by TNF: a road to inflammation
van Loo, G., & Bertrand, M. J. M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00792-3 · Cited by 926
Metadata
- Authors
- Croft, M., Benedict, C. A., & Ware, C. F.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-01-21
- Volume
- 12
- Issue
- 2
- Pages
- 147-168
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2018480371
- Cited by
- 456
- References
- 189
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.